Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website. 

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Your Family History Matters: What Genetic Counseling Can Reveal

Your genes play a meaningful role in your health—shaping everything from your physical features to your risk for certain medical conditions, inclu...

Read More

A Beautiful Heart: Woman, Longtime Karmanos Supporter’s Legacy Lives on Through Generous Gift for Lung Cancer Research

Leslie Cameron Devereaux’s memory lives on at the Barbara Ann Karmanos Cancer Institute in her father’s name, Richard C. Devereaux. Upon her death...

Read More

Karmanos Cancer Institute Welcomes New Medical Oncologist to Thoracic Oncology and Phase I Clinical Trials Teams

The Barbara Ann Karmanos Cancer Institute welcomes Khalil Choucair, M.D., MSc , medical oncologist, to the Thoracic Oncology and Phase I Clinical ...

Read More
News

WSGW | Risks of Pancreatic Cancer

Listen Now

WWJ | Karmanos Psychologist on Emotional Impact of Breast Cancer Diagnosis

Listen Now

WWJ | ‘Houses with Roofs Caved In’: Karmanos Surgeon Explains Stage 0 Breast Cancer (DCIS)

Listen Now
View All Podcasts